These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Gastroduodenal tolerability of nabumetone versus naproxen in the treatment of rheumatic patients. Bianchi Porro G, Montrone F, Petrillo M, Caruso I, Imbesi V. Am J Gastroenterol; 1995 Sep; 90(9):1485-8. PubMed ID: 7661175 [Abstract] [Full Text] [Related]
7. Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases. Friedel HA, Langtry HD, Buckley MM. Drugs; 1993 Jan; 45(1):131-56. PubMed ID: 7680981 [Abstract] [Full Text] [Related]
8. Nabumetone in the treatment of skin and soft tissue injury. Jenner PN. Am J Med; 1987 Oct 30; 83(4B):101-6. PubMed ID: 3318420 [Abstract] [Full Text] [Related]
10. Gastrointestinal blood loss after non-steroidal anti-inflammatory drugs. Measurement by selective determination of faecal porphyrins. Cohen A, Boeijinga JK, van Haard PM, Schoemaker RC, van Vliet-Verbeek A. Br J Clin Pharmacol; 1992 Jan 30; 33(1):33-8. PubMed ID: 1540488 [Abstract] [Full Text] [Related]
11. Results of a six-month study comparing the safety and efficacy of nabumetone and aspirin in the treatment of osteoarthritis. Mullen BJ. Am J Med; 1987 Oct 30; 83(4B):74-7. PubMed ID: 3318433 [Abstract] [Full Text] [Related]
12. Nabumetone induces less gastrointestinal mucosal changes than diclofenac retard. Becvár R, Urbanová Z, Vlasáková V, Vítová J, Rybár I, Maldyk H, Filipowicz-Sosnowska A, Bernacka K, Mackiewicz S, Gömör B, Rojkovich B, Siro B, Bereczki J, Toth K, Sukenik S, Green L, Ehrenfeld M, Pavelka K. Clin Rheumatol; 1999 Oct 30; 18(4):273-8. PubMed ID: 10468165 [Abstract] [Full Text] [Related]
13. Evaluation of nabumetone in the treatment of active adult rheumatoid arthritis. Lanier BG, Turner RA, Collins RL, Senter RG. Am J Med; 1987 Oct 30; 83(4B):40-3. PubMed ID: 3318427 [Abstract] [Full Text] [Related]
14. Treatment of elderly patients with nabumetone or diclofenac: gastrointestinal safety profile. Morgan GJ, Kaine J, DeLapp R, Palmer R. J Clin Gastroenterol; 2001 Apr 30; 32(4):310-4. PubMed ID: 11276273 [Abstract] [Full Text] [Related]
15. Nabumetone: a "nonacidic" nonsteroidal antiinflammatory drug. Dahl SL. Ann Pharmacother; 1993 Apr 30; 27(4):456-63. PubMed ID: 8477124 [Abstract] [Full Text] [Related]
16. The use of a 51Cr technique to detect gastrointestinal microbleeding associated with nonsteroidal antiinflammatory drugs. Lussier A, Arsenault A, Varady J, de Médicis R, Lussier Y, LeBel E. Semin Arthritis Rheum; 1988 Feb 30; 17(3 Suppl 2):40-5. PubMed ID: 3334109 [Abstract] [Full Text] [Related]
17. Acetylsalicylic acid-induced gastrointestinal bleeding determined by a 51Cr method on a day-to-day basis. Dybdahl JH, Daae LN, Larsen S, Ekeli H, Frislid K, Wiik I, Aanstad L. Scand J Gastroenterol; 1980 Feb 30; 15(7):887-95. PubMed ID: 6970979 [Abstract] [Full Text] [Related]
18. Gastrointestinal blood loss of oxaprozin and aspirin with placebo control. Lussier A, LeBel E, Tétreault L. J Clin Pharmacol; 1982 Apr 30; 22(4):173-8. PubMed ID: 6980231 [Abstract] [Full Text] [Related]
19. Gastrointestinal blood loss after diflunisal and after aspirin: effect of ethanol. DeSchepper PJ, Tjandramaga TB, De Roo M, Verhaest L, Daurio C, Steelman SL, Tempero KF. Clin Pharmacol Ther; 1978 Jun 30; 23(6):669-76. PubMed ID: 348379 [Abstract] [Full Text] [Related]
20. Nabumetone therapy of osteoarthritis. A six-week, placebo-controlled study. Blechman WJ. Am J Med; 1987 Oct 30; 83(4B):70-3. PubMed ID: 3318432 [Abstract] [Full Text] [Related] Page: [Next] [New Search]